These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5749219)

  • 1. Deproteinized calf-blood extract, and influence of fibrin stabilising factor (Factor XIII) activity in cirrhosis of the liver.
    Szirmai E
    Agressologie; 1968; 9(4):543-7. PubMed ID: 5749219
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
    Walls WD; Losowsky MS
    Thromb Diath Haemorrh; 1969 Feb; 21(1):134-43. PubMed ID: 5773724
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrin stabilization, factor XIII transamidase activity and subunits "A" and "B" concentration in plasma of patients with liver cirrhosis.
    Kłoczko J; Wereszczyńska U; Wojtukiewicz M; Gybryelewicz A; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):539-44. PubMed ID: 2431976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The activity of fibrinase in cirrhosis of the liver and chronic hepatitis].
    Maliarovskiĭ VN
    Ter Arkh; 1967 Jan; 39(1):61-2. PubMed ID: 5612931
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrin stabilizing factor (factor XIII) activity in liver cirrhosis.
    Yavuzgil C; Karaca M; Göksel V
    New Istanbul Contrib Clin Sci; 1967; 9(2):35-41. PubMed ID: 16300146
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood coagulation disorders in liver cirrhosis in relation to the degree of portal hypertension].
    Klingemann HG; Schmidt U; Brunswig D; Egbring R; Kaffarnik H
    Fortschr Med; 1980 Oct; 98(40):1561-66. PubMed ID: 6970156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XIII in human plasma and platelets.
    McDonagh J; McDonagh RP; Delâge JM; Wagner RH
    J Clin Invest; 1969 May; 48(5):940-6. PubMed ID: 5780202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma fibrin-stabilizing factor activity in acquired disease.
    Walls WD; Losowsky MS
    Br J Haematol; 1968 Sep; 15(3):327. PubMed ID: 5681498
    [No Abstract]   [Full Text] [Related]  

  • 11. Desmofibrin formation and the activity of the fibrin stabilizing factor (FSF) during the cleavage of its SH groups by thrombin.
    Buluk K; Olbromski J; Januszko T; Zuch A
    Thromb Diath Haemorrh; 1966 Jul; 16(1):51-60. PubMed ID: 5989050
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of the thiol groups in the formation of desmofibrin.
    Buluk K; Zuch A
    Pol Med J; 1971; 10(4):886-94. PubMed ID: 5126382
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrin sealants in supporting surgical techniques: strength in factor XIII.
    Phillips M; Dickneite G; Metzner H
    Cardiovasc Surg; 2003 Aug; 11 Suppl 1():13-6. PubMed ID: 12869983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of functional human coagulation factor XIII A-domain in plant cell suspensions and whole plants.
    Gao J; Hooker BS; Anderson DB
    Protein Expr Purif; 2004 Sep; 37(1):89-96. PubMed ID: 15294285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alterations of hemostasis in liver cirrhosis of the dog].
    Mischke R; Pöhle D; Schoon HA; Fehr M; Nolte I
    Dtsch Tierarztl Wochenschr; 1998 Feb; 105(2):43-7. PubMed ID: 9528205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of the fibrin-stabilizing blood coagulation factor XIII in hemorrhages after tooth extractions].
    Vogel C
    Dtsch Zahnarztl Z; 1980 Jan; 35(1):137-8. PubMed ID: 6967809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Duration of life of the fibrin stabilizing factor (factor 13). Therapeutic indications].
    Josso F; Petrova M; Ménaché D; Sizonenko P
    Transfusion (Paris); 1966; 9(4):343-6. PubMed ID: 5966234
    [No Abstract]   [Full Text] [Related]  

  • 19. The monoiodoacetate (MIA) tolerance test, a new quantitative method for the fibrin stabilizing factor (factor 13) assay.
    Sigg P
    Thromb Diath Haemorrh; 1966 Jan; 15(1):238-51. PubMed ID: 5919804
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of fibrin stabilizing factor (FSF) deficiency].
    Amris CJ; Ranek L
    Ugeskr Laeger; 1965 Dec; 127(52):1673-8. PubMed ID: 5868675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.